Department of Gastroenterology, the First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
BMC Gastroenterol. 2020 Feb 18;20(1):39. doi: 10.1186/s12876-020-01189-z.
Hyperuricemia is a major risk for non-alcoholic fatty liver disease. However, the mechanisms for this phenomenon are not fully understood. This study aimed to investigate whether microRNAs mediated the pathogenic effects of uric acid on non-alcoholic fatty liver disease.
Microarray was used to determine the hepatic miRNA expression profiles of male C57BL/6 mice fed on standard chow diet, high fat diet (HFD), and HFD combined with uric acid-lowering therapy by allopurinol. We validated the expression of the most significant differentially expressed microRNAs and explored its role and downstream target in uric acid-induced hepatocytes lipid accumulation.
Microarray analysis and subsequent validation showed that miR-149-5p was significantly up-regulated in the livers of HFD-fed mice, while the expression was down-regulated by allopurinol therapy. MiR-149-5p expression was also significantly up-regulated in uric acid-stimulated hepatocytes. Over-expression of miR-149-5p significantly aggregated uric acid-induced triglyceride accumulation in hepatocytes, while inhibiting miR-149-5p ameliorated the triglyceride accumulation. Luciferase report assay confirmed that FGF21 is a target gene of miR-149-5p. Silencing FGF21 abolished the ameliorative effects of miR-149-5p inhibitor on uric acid-induced hepatocytes lipid accumulation, while overexpression of FGF21 prevented the lipid accumulation induced by miR-149-5p mimics.
Uric acid significantly up-regulated the expression of miR-149-5p in hepatocytes and induced hepatocytes lipid accumulation via regulation of miR-149-5p/FGF21 axis.
高尿酸血症是非酒精性脂肪肝疾病的一个主要危险因素。然而,这一现象的机制尚不完全清楚。本研究旨在探讨微小 RNA 是否介导尿酸对非酒精性脂肪肝疾病的致病作用。
利用微阵列技术检测雄性 C57BL/6 小鼠在标准饲料、高脂肪饮食(HFD)和 HFD 联合别嘌醇降尿酸治疗下的肝组织微小 RNA 表达谱。我们验证了最显著差异表达微小 RNA 的表达,并探讨了其在尿酸诱导的肝细胞脂质积累中的作用及其下游靶标。
微阵列分析和后续验证表明,HFD 喂养的小鼠肝脏中 miR-149-5p 表达显著上调,而别嘌醇治疗可下调其表达。尿酸刺激的肝细胞中 miR-149-5p 的表达也显著上调。过表达 miR-149-5p 可显著聚集尿酸诱导的肝细胞内三酰甘油积累,而抑制 miR-149-5p 可改善三酰甘油积累。荧光素酶报告实验证实 FGF21 是 miR-149-5p 的靶基因。沉默 FGF21 可消除 miR-149-5p 抑制剂对尿酸诱导的肝细胞脂质积累的改善作用,而过表达 FGF21 可防止 miR-149-5p 模拟物诱导的脂质积累。
尿酸可显著上调肝细胞中 miR-149-5p 的表达,并通过 miR-149-5p/FGF21 轴诱导肝细胞脂质积累。